Global Interventional Cardiology Market (2018-2023)
The report is sent in 5-10 business days after order is placed.
Interventional cardiology is the catheter-based treatment of cardiovascular diseases (CVDs). Certified cardiologists who perform these procedures are known as intervention cardiologists. Interventional procedures are specialized examinations designed for the diagnosis or treatment of diseases. It uses minimally invasive technique, performed under the guidance of images, for treating maladies. Interventional procedures in cardiology are carried out using cardiac monitoring and medical devices. According to Netscribes, the global interventional cardiology market is projected to expand at a compound annual growth rate (CAGR) of 7.0% over 2018–2023, generating USD 23.39 Bn in revenue by 2023.
The global interventional cardiology market can be segmented based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.) and based on end user (hospital, catheterization labs, and ambulatory surgical centers).
Type segment insights:
The plaque modification devices market is expected to grow the fastest at a rate of 9.0% during the forecast period (2018-2023) owing to its sustainable benefits such as minimizing vessel trauma and reducing plaque burden. With 27% market share, stents contributed the highest revenue share in 2017. Increase in prevalence of CVDs coupled with benefits of stenting, such as rapid return to normalcy, improving blood flow, and brief hospitalization.
End user segment insights:
Hospitals held the largest market share (48%) in 2017. Ambulatory surgical centers (ASCs) are expected to grow at a significant rate of 9.6% during the 2018-2023 period. With accelerated outpatient procedures, the prominence of ASCs is also swelling.
Regional insights:
The global interventional cardiology market can be divided into regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America led the global interventional cardiology market with a share of 38% in 2017. Asia-Pacific is expected to expand at a CAGR of 7.6% over 2018–2023. Wide adoption of stents is mostly magnifying the market share.
Companies Covered:
1. Medtronic PLC
2. Boston Scientific Corporation
3. Abbott Laboratories S.A.
4. C. R. Bard, Inc.
5. Johnson & Johnson Pvt. Ltd.
6. Edwards Lifesciences Corporation
7. Terumo Corporation
8. LivaNova, PLC.
9. B. Braun Melsungen AG
10. Teleflex Incorporated
11. MicroPort Medical Apparatus (Shanghai) Co. Ltd.
Customizations available
With the given market data, Netscribes offers customizations according to specific needs. , or connect with us here.
Interventional cardiology is the catheter-based treatment of cardiovascular diseases (CVDs). Certified cardiologists who perform these procedures are known as intervention cardiologists. Interventional procedures are specialized examinations designed for the diagnosis or treatment of diseases. It uses minimally invasive technique, performed under the guidance of images, for treating maladies. Interventional procedures in cardiology are carried out using cardiac monitoring and medical devices. According to Netscribes, the global interventional cardiology market is projected to expand at a compound annual growth rate (CAGR) of 7.0% over 2018–2023, generating USD 23.39 Bn in revenue by 2023.
The global interventional cardiology market can be segmented based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.) and based on end user (hospital, catheterization labs, and ambulatory surgical centers).
Type segment insights:
The plaque modification devices market is expected to grow the fastest at a rate of 9.0% during the forecast period (2018-2023) owing to its sustainable benefits such as minimizing vessel trauma and reducing plaque burden. With 27% market share, stents contributed the highest revenue share in 2017. Increase in prevalence of CVDs coupled with benefits of stenting, such as rapid return to normalcy, improving blood flow, and brief hospitalization.
End user segment insights:
Hospitals held the largest market share (48%) in 2017. Ambulatory surgical centers (ASCs) are expected to grow at a significant rate of 9.6% during the 2018-2023 period. With accelerated outpatient procedures, the prominence of ASCs is also swelling.
Regional insights:
The global interventional cardiology market can be divided into regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America led the global interventional cardiology market with a share of 38% in 2017. Asia-Pacific is expected to expand at a CAGR of 7.6% over 2018–2023. Wide adoption of stents is mostly magnifying the market share.
Companies Covered:
1. Medtronic PLC
2. Boston Scientific Corporation
3. Abbott Laboratories S.A.
4. C. R. Bard, Inc.
5. Johnson & Johnson Pvt. Ltd.
6. Edwards Lifesciences Corporation
7. Terumo Corporation
8. LivaNova, PLC.
9. B. Braun Melsungen AG
10. Teleflex Incorporated
11. MicroPort Medical Apparatus (Shanghai) Co. Ltd.
Customizations available
With the given market data, Netscribes offers customizations according to specific needs. , or connect with us here.
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary
CHAPTER 2: GLOBAL INTERVENTIONAL CARDIOLOGY MARKET – OVERVIEW
2.1. Global market overview historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
2.8. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 3: NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET
3.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
3.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
3.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 4: EUROPE INTERVENTIONAL CARDIOLOGY MARKET
4.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
4.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
4.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 5: ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY MARKET
5.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
5.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
5.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 6: LATIN AMERICA INTERVENTIONAL CARDIOLOGY MARKET
6.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
6.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
6.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 7: THE MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY MARKET
7.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
7.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
7.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Medtronic PLC
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
8.2. Boston Scientific Corporation
8.2.a. Company snapshot
8.2.b. Product offerings
8.2.c. Growth strategies
8.2.d. Initiatives
8.2.e. Geographical presence
8.2.f. Key numbers
8.3. Abbott Laboratories S.A.
8.3.a. Company snapshot
8.3.b. Product offerings
8.3.c. Growth strategies
8.3.d. Initiatives
8.3.e. Geographical presence
8.3.f. Key numbers
8.4. C. R. Bard, Inc.
8.4.a. Company snapshot
8.4.b. Product offerings
8.4.c. Growth strategies
8.4.d. Initiatives
8.4.e. Geographical presence
8.4.f. Key numbers
8.5. Johnson & Johnson Pvt. Ltd.
8.5.a. Company snapshot
8.5.b. Product offerings
8.5.c. Growth strategies
8.5.d. Initiatives
8.5.e. Geographical presence
8.5.f. Key numbers
8.6. Edwards Lifesciences Corporation
8.6.a. Company snapshot
8.6.b. Product offerings
8.6.c. Growth strategies
8.6.d. Initiatives
8.6.e. Geographical presence
8.6.f. Key numbers
8.7. Terumo Corporation
8.7.a. Company snapshot
8.7.b. Product offerings
8.7.c. Growth strategies
8.7.d. Initiatives
8.7.e. Geographical presence
8.7.f. Key numbers
8.8. LivaNova, PLC.
8.8.a. Company snapshot
8.8.b. Product offerings
8.8.c. Growth strategies
8.8.d. Initiatives
8.8.e. Geographical presence
8.8.f. Key numbers
8.9. B. Braun Melsungen AG
8.9.a. Company snapshot
8.9.b. Product offerings
8.9.c. Growth strategies
8.9.d. Initiatives
8.9.e. Geographical presence
8.9.f. Key numbers
8.10. Teleflex Incorporated
8.10.a. Company snapshot
8.10.b. Product offerings
8.10.c. Growth strategies
8.10.d. Initiatives
8.10.e. Geographical presence
8.10.f. Key numbers
8.11. MicroPort Medical Apparatus (Shanghai) Co. Ltd.
8.11.a. Company snapshot
8.11.b. Product offerings
8.11.c. Growth strategies
8.11.d. Initiatives
8.11.e. Geographical presence
8.11.f. Key numbers
CHAPTER 9: CONCLUSION
9.1. Future Outlook
Appendix
1. List of tables
2. Research methodology
3. Assumptions
4. About Netscribes, Inc.
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary
CHAPTER 2: GLOBAL INTERVENTIONAL CARDIOLOGY MARKET – OVERVIEW
2.1. Global market overview historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
2.8. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 3: NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET
3.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
3.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
3.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 4: EUROPE INTERVENTIONAL CARDIOLOGY MARKET
4.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
4.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
4.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 5: ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY MARKET
5.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
5.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
5.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 6: LATIN AMERICA INTERVENTIONAL CARDIOLOGY MARKET
6.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
6.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
6.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 7: THE MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY MARKET
7.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
7.2. Market segmentation based on type (stents, catheters, PTCA balloons, plaque modification devices, embolic protection devices, vascular closure devices, chronic total occlusion, imaging systems, guidewires, and others [accessories, introducer sheath, etc.]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key market observations
7.3. Market segmentation based on end user (hospital, catheterization labs, and ambulatory surgical centers) – historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), and key observations
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Medtronic PLC
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
8.2. Boston Scientific Corporation
8.2.a. Company snapshot
8.2.b. Product offerings
8.2.c. Growth strategies
8.2.d. Initiatives
8.2.e. Geographical presence
8.2.f. Key numbers
8.3. Abbott Laboratories S.A.
8.3.a. Company snapshot
8.3.b. Product offerings
8.3.c. Growth strategies
8.3.d. Initiatives
8.3.e. Geographical presence
8.3.f. Key numbers
8.4. C. R. Bard, Inc.
8.4.a. Company snapshot
8.4.b. Product offerings
8.4.c. Growth strategies
8.4.d. Initiatives
8.4.e. Geographical presence
8.4.f. Key numbers
8.5. Johnson & Johnson Pvt. Ltd.
8.5.a. Company snapshot
8.5.b. Product offerings
8.5.c. Growth strategies
8.5.d. Initiatives
8.5.e. Geographical presence
8.5.f. Key numbers
8.6. Edwards Lifesciences Corporation
8.6.a. Company snapshot
8.6.b. Product offerings
8.6.c. Growth strategies
8.6.d. Initiatives
8.6.e. Geographical presence
8.6.f. Key numbers
8.7. Terumo Corporation
8.7.a. Company snapshot
8.7.b. Product offerings
8.7.c. Growth strategies
8.7.d. Initiatives
8.7.e. Geographical presence
8.7.f. Key numbers
8.8. LivaNova, PLC.
8.8.a. Company snapshot
8.8.b. Product offerings
8.8.c. Growth strategies
8.8.d. Initiatives
8.8.e. Geographical presence
8.8.f. Key numbers
8.9. B. Braun Melsungen AG
8.9.a. Company snapshot
8.9.b. Product offerings
8.9.c. Growth strategies
8.9.d. Initiatives
8.9.e. Geographical presence
8.9.f. Key numbers
8.10. Teleflex Incorporated
8.10.a. Company snapshot
8.10.b. Product offerings
8.10.c. Growth strategies
8.10.d. Initiatives
8.10.e. Geographical presence
8.10.f. Key numbers
8.11. MicroPort Medical Apparatus (Shanghai) Co. Ltd.
8.11.a. Company snapshot
8.11.b. Product offerings
8.11.c. Growth strategies
8.11.d. Initiatives
8.11.e. Geographical presence
8.11.f. Key numbers
CHAPTER 9: CONCLUSION
9.1. Future Outlook
Appendix
1. List of tables
2. Research methodology
3. Assumptions
4. About Netscribes, Inc.
